Anatomic Molecular Pathology: An Emerging Field

More documents

Recommendations

Info

Oncotype DX is validated for use inbreast cancer patientsMultigeneExpression Assay (RTPCR)to Predict Recurrence of TamoxifenTreated, NodeNegative Negative Breast CancerSelection of Patients for ChemotherapyS.Paik et al. NEJM. 351:28172826, 2826, 2004
Pathwork Tissueof Origin Test• Gene expressionmicroarraybased test•Helps identify tissue oforigin of poorly &undifferentiated cancers•15 tissue typesCancerTYPE<strong>Molecular</strong>Classification Test•92gene realtimequantitative PCR assay•<strong>Molecular</strong> classificationof human cancers•39 tumor classes
Page 3 and 4: Anatomic Pathology• Surgical Path
Page 5 and 6: Surgical PathologySR086XXDiagnosi
Page 8 and 9: Tissue Based Molecular Tests forHer
Page 10 and 11: Algorithm forLaboratoryTestingfor H
Page 12 and 13: COLORECTAL ADENOCARCINOMA:‣High L
Page 14 and 15: Distinction of HNPCC and Sporadic M
Page 16 and 17: EPIDERMAL GROWTH FACTORRECEPTOR (EG
Page 18 and 19: Distribution of Mutations andRespon
Page 22 and 23: Molecular Diagnosis of InfectiousAg
Page 24 and 25: Career Opportunities in MolecularAn

Anatomic Molecular Pathology: An Emerging Field

Create successful ePaper yourself

Delete template?

Save as template?